...a Series C with a total raise of $209 million. Axios, Butterfly Network, which some years back developed a hand-held ultrasound device (Butterfly iQ) and entered a crowded field with GE HealthCare’s VScan, Mobisante (apparently defunct), and Philips Lumify, reported Q1 revenue of $15.5 million, flat year-over-year compared to Q1 2022 and which missed analyst estimates (again). Somewhat better news was narrowing last year’s loss to a Q1 loss of $33.5 million which was less than Q1 2022’s loss of $44.5 million. It’s another early SPAC that hasn’t had a great time of it. Since its debut on the NYSE... Continue Reading
Search Results for vscan
News and funding roundup: BioIntelliSense ‘stickers’ $45M, Exo ultrasound scans $220M, Enovation gets Scotland OK, WellSky snaps up Healthify, Cerner’s good quarter despite VA
...510(k) FDA-cleared; the BioButton is not, but is being marketed as an enterprise solution for employee health clearance. Mobihealthnews Hand-held ultrasound gets ultra-funding. The Exo hand-held ultrasound snagged a hefty $220 million in Series C funding for a total of over $320 million since last year. Their point-of-care tool includes nano-materials, sensor technology, and advanced signal processing and computation in a platform called Exo Works. Exo is in a crowded field pioneered by GE Healthcare’s Vscan [TTA 27 March] back in 2010, but including Butterfly IQ, Mobisante, and Philips Lumify. Mobihealthnews Enovation also approved by Scotland. With our news from... Continue Reading
Deals and news roundup: Ginger’s $100M, myNEXUS to Anthem, Everlywell snaps up PWN, Amwell’s banner year for revenue–and loss, VA reviews Cerner rollout, voice visits for MA, GE’s vScan goes wireless, uBiome founders indicted
...heard from GEHC since till this month, and other competitors, such as the Butterfly IQ from 4Catalyzer, have made handheld ultrasound common and affordable. GEHC announced Vscan Air, a fully wireless version that connects to iOS or Android. It was FDA cleared in November 2020 and will be shipping its dual-headed probe and accessories starting 1 April for a US-listed target price of $4,495. GEHC page (with the cute domain vscan.rocks), Mobihealthnews And in our Scandal Sheet section, a Federal grand jury in the Northern District of California has indicted the founders of now-bankrupt uBiome on 40-odd counts encompassing conspiracy... Continue Reading
After the COVID Deluge: a Topol-esque view of what (tele)medicine will look like
A typically cheery view by Eric Topol, MD of what medical practice will look like after COVID is over. With the full court press to go remote in hospitals and practices worldwide, telehealth and telemedicine has gone fast forward in a matter of under two months. But what will it look like after it’s over? Most of what the good doctor is prognosticating will be familiar to our Readers who’ve followed him for years–certainly he was right on mobile health overall and especially AliveCor/Kardia Mobile— but not so on point with mobile body scanners (anyone remember VScan?) When the high... Continue Reading
Comings and goings, short takes, and in other news…: Vivify’s new SVP Sales, Parks’ Connected Health Summit, $35M for 3D portable ultrasound, Oxford Medical Sim new pilot
...their Twitter feed at @CONN_Health_Smt | Hashtag: #CONNHealth19. And register here. This Editor has been following handheld ultrasound since GE Healthcare debuted the VScan in what seems an eternity ago (only 2010!) –and yes, it’s still around–Mobisante demonstrated at TED by no less than Eric Dishman in 2013–and last year the locally-based Butterfly IQ hit the market at about half the price and raised $250 million. Now Redwood City, California startup Exo Imaging has gained a $35 million Series B round to develop its portable ultrasound that through AI assistance generates a 3D image. Release. Mobihealthnews The UK’s Oxford Medical... Continue Reading
Butterfly IQ handheld ultrasound offers clinical-quality body imaging for under $2,000
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2018/03/butterfly-iq.jpg” thumb_width=”200″ /]Butterfly IQ is a NYC and Connecticut-based company which has developed a handheld ultrasound that transmits images to a smartphone. Where it differs from current handhelds like GE’s VScan is that it uses a single transducer for all images both near-field and deeper in body, and connects to a iPhone loaded with their software. Larger machines, even on portable carts like the Philips Lumify [TTA 27 Mar] operate on an older vibrating crystals-based technology. The IQ uses capacitive micro-machined ultrasound transducers or CMUTs. It claims to be FDA-cleared for 13 applications. All this is delivered for under... Continue Reading
GE moving out of the hospital EHR business–and healthcare lending?
...healthcare financing to support what it makes in its GE Healthcare unit: ultrasound, imaging, patient monitoring and diagnostics industrial equipment, down to the Vscan (yes! it’s still there). We would bet that GE Ventures is safe. But does this mean that its healthcare real estate unit within Healthcare Financial Services, which lends to senior housing, skilled nursing and other medical properties, is on the block, especially as GE this weekend completed the sale of its real estate holdings? What else, we wonder, will GE sell at the right price to pull up share price–and in the longer term, the future... Continue Reading
NYeC Digital Health: two diverging visions of a connected future (Part 1)
...tests are increasingly DIY, with smartphones capable of doing assays and Theranos’ inexpensive tests from a few drops of blood using microfluidics technology, available direct to consumer at a drugstore. Imaging devices are again smartphone based–CellScope‘s otoscope, Peek (eye) and GE’s VScan ultrasound (yes, it is still around) lead to less expensive home or retail-based physical exams. And the results would be owned by the patient. The PHR doesn’t go far enough for him–the patient would own their data, all of it, from day one. Medications are also expensive (in the US, the top ten drugs account for $62 bn... Continue Reading
A question for our readers: what does it take for health tech to cross borders well?
...it is purchased by a multi-national organization, cautiousness takes hold. Much of the liveliness of PERS market leader Lifeline has dimmed since Philips acquired it about 2008, and even its innovations are hardly noticed in the US. Care Innovations‘ products didn’t travel well (although QuietCare did achieve a UK footprint in the early LIG days of 2006-8). Despite our large Latino population in the US, Telefónica has never entered the US market. Alcatel-Lucent (Bell Labs) is not prominent here despite its heritage. GE Healthcare’s much-hyped Vscan ultrasound device is still on GE’s website, but not heard from since the Winter... Continue Reading
Health tech growing fast in Brazil and Asia-Pacific
...for home care, containing a GE Vscan portable ultrasound, a TuffSat pulse oximeter, an Accutrend blood monitor, an EKG machine, a blood pressure monitor, a weight scale, a digital thermometer, tape measure and stethoscope. Savings were about $200,000 per 100 patients/year. Mobihealthnews. [grow_thumb image=”https://telecareaware.com/wp-content/uploads/2013/02/gimlet-eye.jpg” thumb_width=”100″ /] The Gimlet Eye, having read this, just sent a message to your Editor. Could it be The Eye’s undisclosed location? Perhaps we should be… ‘Flying Down to Rio’? In Asia-Pacific, the $55 billion APAC medical devices market–nearly 25 percent of the world market– is expected to grow over 10 percent per year over the... Continue Reading
Most Recent Comments